DUBLIN--(BUSINESS WIRE)--The new research portal has an extensive collection of company research on Teva Pharmaceuticals, including in-depth analysis of their current market position and future outlook within the pharma industry. Teva develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide.
One such report available on the portal, Global Erythropoietin Drugs Market report, forecasts the market to grow at a CAGR of 0.79% during the period 2017-2021. One trend in market is advent of biosimilars expected to improve the treatment rates. The growing demand for quality care has led to the increased use of erythropoietin drugs for the treatment of various diseases, including cancer and blood disorders. Countries worldwide are under pressure to address this demand without increasing healthcare expenditure. Biosimilars are likely to play a prominent role in this scenario, as unlike generic drugs, they have identical active pharmaceutical ingredients to their originator biologic compounds. Biosimilars are less expensive than biologics, thereby increasing accessibility. The patent expiry of biologics has led to the emergence of their biosimilars.
“The portal is an invaluable resource for anyone seeking information on Teva Pharmaceuticals and their activities in various industries. It provides quick, and easy access to information on their performance as a company and their overall impact on the market,” says Ross Glover, CEO of Research and Markets.
For more information visit http://www.researchandmarkets.com/companies/teva-pharmaceutical-industries-ltd?cid=7cspnr
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest collection of business information products on the market. We offer the most in-depth market analysis across a multitude of industries. Our products provide clients with an unrivalled understanding of their chosen market. No matter how specialist your field, we have the insights and market data to help you make efficient and effective decisions.